Betadine 5% recalled over sterility concerns
- Recall date
- April 12, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Edge Pharma, LLC recalls Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT)…
- Recall number
- D-0335-2021
- FDA classification
- Class II
- Brand / firm
- Edge Pharma, LLC
- Sold / distributed
- Nationwide in the US
Why it was recalled
Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178
Get recall alerts
Free email alert whenever Edge Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Edge Pharma, LLC